Daniel Rolnik
A/Prof Daniel Rolnik is an early career researcher and clinical epidemiologist who studied Medicine and specialised in Obstetrics and Gynaecology in Brazil (University of Sao Paulo), subspecialised in Fetal Medicine (Fetal Medicine Foundation / King's College Hospital, London, UK) and in Maternal-Fetal Medicine - High risk pregnancy (Monash University - Australia). He also completed a Master in Public Health (MPH) in Epidemiology at Harvard University (USA).
A/Prof Rolnik's main research interest is in Obstetrics and Gynaecology, Prevention of pregnancy complications, Prenatal diagnosis and Early pregnancy screening. In the last 5 years, he has authored more than 200 peer-reviewed publications (over 10,000 citations, H-index 39 (Google Scholar), and has published in leading journals including NEJM, Lancet, JAMA, BMJ Open, American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, Human Reproduction, and Ultrasound in Obstetrics and Gynecology. A/Prof Rolnik led and first-authored a European multicentre landmark randomised trial on the prediction and prevention of pre-eclampsia involving nearly 27,000 screened women in 13 hospitals and six European countries. This study, published in NEJM, has over 2700 citations and has transformed routine clinical care globally.
A/Prof Rolnik serves as the Deputy Head of the Department of Obstetrics and Gynecology. He was named Australia's Top Researcher in Obstetrics & Gynecology in 2023.
Find out more from A/Prof Daniel Rolnik's Monash profile.